Aktienkurs

Datum	Shanghai Pharmaceuticals Holding Co Omzet	Shanghai Pharmaceuticals Holding Co EBIT	Shanghai Pharmaceuticals Holding Co Winst
2026e	357,23 mld. undefined	12,63 mld. undefined	3,50 mld. undefined
2025e	322,76 mld. undefined	11,21 mld. undefined	3,04 mld. undefined
2024e	291,16 mld. undefined	9,86 mld. undefined	2,70 mld. undefined
2023	260,30 mld. undefined	8,86 mld. undefined	3,77 mld. undefined
2022	231,98 mld. undefined	8,32 mld. undefined	5,62 mld. undefined
2021	215,82 mld. undefined	7,80 mld. undefined	5,09 mld. undefined
2020	191,91 mld. undefined	7,74 mld. undefined	4,50 mld. undefined
2019	186,57 mld. undefined	7,37 mld. undefined	4,08 mld. undefined
2018	159,08 mld. undefined	5,71 mld. undefined	3,88 mld. undefined
2017	130,85 mld. undefined	5,06 mld. undefined	3,52 mld. undefined
2016	120,77 mld. undefined	3,74 mld. undefined	3,20 mld. undefined
2015	105,52 mld. undefined	3,62 mld. undefined	2,88 mld. undefined
2014	92,40 mld. undefined	3,21 mld. undefined	2,59 mld. undefined
2013	78,22 mld. undefined	2,79 mld. undefined	2,24 mld. undefined
2012	68,08 mld. undefined	2,55 mld. undefined	2,05 mld. undefined
2011	54,90 mld. undefined	2,34 mld. undefined	2,04 mld. undefined
2010	38,53 mld. undefined	1,76 mld. undefined	1,27 mld. undefined
2009	31,26 mld. undefined	1,28 mld. undefined	1,30 mld. undefined
2008	16,55 mld. undefined	208,00 mln. undefined	82,00 mln. undefined
2007	13,92 mld. undefined	220,00 mln. undefined	66,00 mln. undefined
2006	12,64 mld. undefined	120,00 mln. undefined	-39,00 mln. undefined
2005	10,70 mld. undefined	90,00 mln. undefined	51,00 mln. undefined
2004	10,82 mld. undefined	121,00 mln. undefined	90,00 mln. undefined

	Omzet	EBIT	Winst
2004	10,82 mld. CNY	121,00 mln. CNY	90,00 mln. CNY
2005	10,70 mld. CNY	90,00 mln. CNY	51,00 mln. CNY
2006	12,64 mld. CNY	120,00 mln. CNY	-39,00 mln. CNY
2007	13,92 mld. CNY	220,00 mln. CNY	66,00 mln. CNY
2008	16,55 mld. CNY	208,00 mln. CNY	82,00 mln. CNY
2009	31,26 mld. CNY	1,28 mld. CNY	1,30 mld. CNY
2010	38,53 mld. CNY	1,76 mld. CNY	1,27 mld. CNY
2011	54,90 mld. CNY	2,34 mld. CNY	2,04 mld. CNY
2012	68,08 mld. CNY	2,55 mld. CNY	2,05 mld. CNY
2013	78,22 mld. CNY	2,79 mld. CNY	2,24 mld. CNY
2014	92,40 mld. CNY	3,21 mld. CNY	2,59 mld. CNY
2015	105,52 mld. CNY	3,62 mld. CNY	2,88 mld. CNY
2016	120,77 mld. CNY	3,74 mld. CNY	3,20 mld. CNY
2017	130,85 mld. CNY	5,06 mld. CNY	3,52 mld. CNY
2018	159,08 mld. CNY	5,71 mld. CNY	3,88 mld. CNY
2019	186,57 mld. CNY	7,37 mld. CNY	4,08 mld. CNY
2020	191,91 mld. CNY	7,74 mld. CNY	4,50 mld. CNY
2021	215,82 mld. CNY	7,80 mld. CNY	5,09 mld. CNY
2022	231,98 mld. CNY	8,32 mld. CNY	5,62 mld. CNY
2023	260,30 mld. CNY	8,86 mld. CNY	3,77 mld. CNY
2024e	291,16 mld. CNY	9,86 mld. CNY	2,70 mld. CNY
2025e	322,76 mld. CNY	11,21 mld. CNY	3,04 mld. CNY
2026e	357,23 mld. CNY	12,63 mld. CNY	3,50 mld. CNY

Shanghai Pharmaceuticals Holding Co Brutomarge	Shanghai Pharmaceuticals Holding Co Winstmarge	Shanghai Pharmaceuticals Holding Co EBIT-marge	Shanghai Pharmaceuticals Holding Co Winstmarge
2026e	11,92 %	3,54 %	0,98 %
2025e	11,92 %	3,47 %	0,94 %
2024e	11,92 %	3,39 %	0,93 %
2023	11,92 %	3,40 %	1,45 %
2022	13,14 %	3,58 %	2,42 %
2021	13,20 %	3,61 %	2,36 %
2020	14,09 %	4,03 %	2,34 %
2019	14,22 %	3,95 %	2,19 %
2018	13,96 %	3,59 %	2,44 %
2017	12,73 %	3,87 %	2,69 %
2016	11,73 %	3,10 %	2,65 %
2015	11,92 %	3,43 %	2,73 %
2014	12,24 %	3,48 %	2,80 %
2013	12,98 %	3,56 %	2,87 %
2012	13,56 %	3,75 %	3,02 %
2011	14,31 %	4,25 %	3,72 %
2010	17,71 %	4,57 %	3,29 %
2009	18,71 %	4,08 %	4,15 %
2008	8,60 %	1,26 %	0,50 %
2007	8,63 %	1,58 %	0,47 %
2006	8,26 %	0,95 %	-0,31 %
2005	6,41 %	0,84 %	0,48 %
2004	9,24 %	1,12 %	0,83 %

	Brutomarge	EBIT-marge	Winstmarge
2004	9,24 %	1,12 %	0,83 %
2005	6,41 %	0,84 %	0,48 %
2006	8,26 %	0,95 %	-0,31 %
2007	8,63 %	1,58 %	0,47 %
2008	8,60 %	1,26 %	0,50 %
2009	18,71 %	4,08 %	4,15 %
2010	17,71 %	4,57 %	3,29 %
2011	14,31 %	4,25 %	3,72 %
2012	13,56 %	3,75 %	3,02 %
2013	12,98 %	3,56 %	2,87 %
2014	12,24 %	3,48 %	2,80 %
2015	11,92 %	3,43 %	2,73 %
2016	11,73 %	3,10 %	2,65 %
2017	12,73 %	3,87 %	2,69 %
2018	13,96 %	3,59 %	2,44 %
2019	14,22 %	3,95 %	2,19 %
2020	14,09 %	4,03 %	2,34 %
2021	13,20 %	3,61 %	2,36 %
2022	13,14 %	3,58 %	2,42 %
2023	11,92 %	3,40 %	1,45 %
2024e	11,92 %	3,39 %	0,93 %
2025e	11,92 %	3,47 %	0,94 %
2026e	11,92 %	3,54 %	0,98 %

Datum	Shanghai Pharmaceuticals Holding Co Omzet per aandeel	Shanghai Pharmaceuticals Holding Co EBIT per aandeel	Shanghai Pharmaceuticals Holding Co Winst per aandeel
2026e	184,95 undefined	0 undefined	1,81 undefined
2025e	167,10 undefined	0 undefined	1,57 undefined
2024e	150,74 undefined	0 undefined	1,40 undefined
2023	70,33 undefined	2,39 undefined	1,02 undefined
2022	66,61 undefined	2,39 undefined	1,61 undefined
2021	75,85 undefined	2,74 undefined	1,79 undefined
2020	67,43 undefined	2,72 undefined	1,58 undefined
2019	65,83 undefined	2,60 undefined	1,44 undefined
2018	56,23 undefined	2,02 undefined	1,37 undefined
2017	48,66 undefined	1,88 undefined	1,31 undefined
2016	44,91 undefined	1,39 undefined	1,19 undefined
2015	39,24 undefined	1,35 undefined	1,07 undefined
2014	34,36 undefined	1,19 undefined	0,96 undefined
2013	29,09 undefined	1,04 undefined	0,83 undefined
2012	25,32 undefined	0,95 undefined	0,76 undefined
2011	22,68 undefined	0,96 undefined	0,84 undefined
2010	19,33 undefined	0,88 undefined	0,64 undefined
2009	15,69 undefined	0,64 undefined	0,65 undefined
2008	29,08 undefined	0,37 undefined	0,14 undefined
2007	24,46 undefined	0,39 undefined	0,12 undefined
2006	22,21 undefined	0,21 undefined	-0,07 undefined
2005	18,80 undefined	0,16 undefined	0,09 undefined
2004	19,01 undefined	0,21 undefined	0,16 undefined

	Omzet per aandeel	EBIT per aandeel	Winst per aandeel
2004	19,01 CNY	0,21 CNY	0,16 CNY
2005	18,80 CNY	0,16 CNY	0,09 CNY
2006	22,21 CNY	0,21 CNY	-0,07 CNY
2007	24,46 CNY	0,39 CNY	0,12 CNY
2008	29,08 CNY	0,37 CNY	0,14 CNY
2009	15,69 CNY	0,64 CNY	0,65 CNY
2010	19,33 CNY	0,88 CNY	0,64 CNY
2011	22,68 CNY	0,96 CNY	0,84 CNY
2012	25,32 CNY	0,95 CNY	0,76 CNY
2013	29,09 CNY	1,04 CNY	0,83 CNY
2014	34,36 CNY	1,19 CNY	0,96 CNY
2015	39,24 CNY	1,35 CNY	1,07 CNY
2016	44,91 CNY	1,39 CNY	1,19 CNY
2017	48,66 CNY	1,88 CNY	1,31 CNY
2018	56,23 CNY	2,02 CNY	1,37 CNY
2019	65,83 CNY	2,60 CNY	1,44 CNY
2020	67,43 CNY	2,72 CNY	1,58 CNY
2021	75,85 CNY	2,74 CNY	1,79 CNY
2022	66,61 CNY	2,39 CNY	1,61 CNY
2023	70,33 CNY	2,39 CNY	1,02 CNY
2024e	150,74 CNY	0 CNY	1,40 CNY
2025e	167,10 CNY	0 CNY	1,57 CNY
2026e	184,95 CNY	0 CNY	1,81 CNY

	Aantal aandelen
2004	569,00 mln. Aktien
2005	569,00 mln. Aktien
2006	569,00 mln. Aktien
2007	569,00 mln. Aktien
2008	569,00 mln. Aktien
2009	1,99 mld. Aktien
2010	1,99 mld. Aktien
2011	2,42 mld. Aktien
2012	2,69 mld. Aktien
2013	2,69 mld. Aktien
2014	2,69 mld. Aktien
2015	2,69 mld. Aktien
2016	2,69 mld. Aktien
2017	2,69 mld. Aktien
2018	2,83 mld. Aktien
2019	2,83 mld. Aktien
2020	2,85 mld. Aktien
2021	2,85 mld. Aktien
2022	3,48 mld. Aktien
2023	3,70 mld. Aktien
2024e	3,70 mld. Aktien
2025e	3,70 mld. Aktien
2026e	3,70 mld. Aktien

Datum	Shanghai Pharmaceuticals Holding Co Dividend
2026e	0,65 undefined
2025e	0,65 undefined
2024e	0,65 undefined
2023	0,61 undefined
2022	0,42 undefined
2021	0,48 undefined
2020	0,44 undefined
2019	0,41 undefined
2018	0,38 undefined
2017	0,36 undefined
2016	0,33 undefined
2015	0,29 undefined
2014	0,26 undefined
2013	0,24 undefined
2012	0,16 undefined
2011	0,14 undefined
2010	0,10 undefined
2009	0,05 undefined
2008	0,05 undefined
2006	0,10 undefined
2005	0,07 undefined
2004	0,07 undefined

	Dividend	Dividend (schatting)
2004	0,07 CNY	0 CNY
2005	0,07 CNY	0 CNY
2006	0,10 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0,05 CNY	0 CNY
2009	0,05 CNY	0 CNY
2010	0,10 CNY	0 CNY
2011	0,14 CNY	0 CNY
2012	0,16 CNY	0 CNY
2013	0,24 CNY	0 CNY
2014	0,26 CNY	0 CNY
2015	0,29 CNY	0 CNY
2016	0,33 CNY	0 CNY
2017	0,36 CNY	0 CNY
2018	0,38 CNY	0 CNY
2019	0,41 CNY	0 CNY
2020	0,44 CNY	0 CNY
2021	0,48 CNY	0 CNY
2022	0,42 CNY	0 CNY
2023	0,61 CNY	0 CNY
2024e	0 CNY	0,65 CNY
2025e	0 CNY	0,65 CNY
2026e	0 CNY	0,65 CNY

Datum	Shanghai Pharmaceuticals Holding Co Uitkeringspercentage
2026e	26,67 %
2025e	26,51 %
2024e	26,59 %
2023	26,90 %
2022	26,04 %
2021	26,82 %
2020	27,85 %
2019	28,47 %
2018	27,74 %
2017	27,48 %
2016	27,73 %
2015	27,10 %
2014	27,08 %
2013	28,92 %
2012	21,05 %
2011	16,67 %
2010	15,94 %
2009	6,92 %
2008	35,71 %
2007	26,90 %
2006	-148,81 %
2005	74,07 %
2004	46,87 %

	Uitkeringspercentage
2004	46,87 %
2005	74,07 %
2006	-148,81 %
2007	26,90 %
2008	35,71 %
2009	6,92 %
2010	15,94 %
2011	16,67 %
2012	21,05 %
2013	28,92 %
2014	27,08 %
2015	27,10 %
2016	27,73 %
2017	27,48 %
2018	27,74 %
2019	28,47 %
2020	27,85 %
2021	26,82 %
2022	26,04 %
2023	26,90 %
2024e	26,59 %
2025e	26,51 %
2026e	26,67 %

Datum	EPS-schatting	EPS-Actueel	Rapportagekwartaal
31-3-2024	1,53	0,42 (-72,63 %)	2024 Q1
31-12-2023	0,53	-0,01 (-101,90 %)	2023 Q4
30-9-2023	0,45	0,32 (-29,59 %)	2023 Q3
30-6-2023	0,65	0,30 (-53,59 %)	2023 Q2
31-3-2023	0,40	0,41 (1,49 %)	2023 Q1
31-12-2022	-0,29	0,16 (154,63 %)	2022 Q4
30-9-2022	0,36	0,30 (-17,49 %)	2022 Q3
30-6-2022	0,45	0,66 (45,46 %)	2022 Q2
31-3-2022	0,57	0,44 (-22,21 %)	2022 Q1
31-12-2021	0,24	0,21 (-13,37 %)	2021 Q4
30-9-2021	0,53	0,32 (-39,07 %)	2021 Q3
30-6-2021	0,68	0,51 (-24,17 %)	2021 Q2
31-3-2021	0,51	0,75 (48,51 %)	2021 Q1
31-12-2020	0,40	0,31 (-23,27 %)	2020 Q4
30-9-2020	0,26	0,41 (56,13 %)	2020 Q3
30-6-2020	0,45	0,49 (7,81 %)	2020 Q2
31-3-2020	0,38	0,37 (-1,52 %)	2020 Q1
31-12-2019	0,36	0,24 (-32,71 %)	2019 Q4
30-9-2019	0,37	0,39 (6,18 %)	2019 Q3
30-6-2019	0,41	0,41 (-0,23 %)	2019 Q2
31-3-2019	0,41	0,40 (-4,30 %)	2019 Q1
31-12-2018	0,30	0,18 (-39,93 %)	2018 Q4
30-9-2018	0,31	0,47 (51,33 %)	2018 Q3
30-6-2018	0,29	0,36 (21,54 %)	2018 Q2
31-3-2018	0,37	0,37 (-2,19 %)	2018 Q1
31-12-2017	0,30	0,31 (1,54 %)	2017 Q4
30-9-2017	0,29	0,28 (-2,20 %)	2017 Q3
30-6-2017	0,46	0,34 (-25,36 %)	2017 Q2
31-3-2017	0,34	0,37 (7,93 %)	2017 Q1
31-12-2016	0,30	0,27 (-7,84 %)	2016 Q4
30-9-2016	0,29	0,27 (-5,97 %)	2016 Q3
30-6-2016	0,32	0,31 (-3,08 %)	2016 Q2
31-3-2016	0,28	0,33 (18,52 %)	2016 Q1
31-12-2015	0,28	0,26 (-8,19 %)	2015 Q4
30-9-2015	0,26	0,24 (-7,09 %)	2015 Q3
30-6-2015	0,32	0,30 (-8,19 %)	2015 Q2
31-3-2015	0,26	0,27 (3,96 %)	2015 Q1
31-12-2014	0,22	0,25 (14,96 %)	2014 Q4
30-9-2014	0,22	0,22 (1,05 %)	2014 Q3
30-6-2014	0,27	0,27 (-0,93 %)	2014 Q2
31-3-2014	0,24	0,22 (-10,80 %)	2014 Q1
31-12-2013	0,21	0,21 (-1,92 %)	2013 Q4
30-9-2013	0,22	0,18 (-15,78 %)	2013 Q3
30-6-2013	0,22	0,21 (-5,52 %)	2013 Q2
31-12-2012	0,18	0,19 (2,27 %)	2012 Q4
30-9-2011	0,19	0,15 (-20,27 %)	2011 Q3
30-6-2011	0,21	0,06 (-72,18 %)	2011 Q2

%	Naam	Aandelen	Verandering	Datum
37,10 %	Shanghai Pharmaceutical (Group) Co. Ltd.	716.516.039	0	31-12-2023
34,46 %	Yunnan Baiyao Group Co., Ltd.	665.626.796	0	31-12-2023
32,62 %	Shanghai Industrial Investment (Holdings) Co., Ltd.	629.987.798	220.686.000	31-12-2023
2,31 %	Shanghai Guosheng (Group) Co., Ltd.	44.632.100	23.762.800	31-12-2023
1,12 %	Yinhua Fund Management Co., Ltd.	21.712.597	10.111.375	31-12-2023
0,87 %	E Fund Management Co. Ltd.	16.734.637	-784.660	31-12-2023
0,64 %	Orient Securities Asset Management Company Limited	12.449.700	12.449.700	30-6-2023
0,57 %	Fullgoal Fund Management Co., Ltd.	11.000.000	118.000	31-12-2023
0,56 %	China Universal Asset Management Co., Ltd.	10.839.871	-1.102.100	31-12-2023
0,46 %	Huatai-PineBridge Fund Management Co., Ltd.	8.874.912	4.450.669	31-12-2023
0,46 %	China Southern Asset Management Co. Ltd.	8.860.445	-5.800	31-12-2023
0,46 %	GF Fund Management Co., Ltd.	8.801.380	-2.289.400	31-12-2023
0,44 %	Norges Bank Investment Management (NBIM)	8.406.130	-445.828	31-12-2023
0,36 %	Lion Fund Management Co., Ltd.	6.997.832	-169.000	31-12-2023
0,29 %	The Vanguard Group, Inc.	5.613.896	0	31-3-2024
0,29 %	BlackRock Institutional Trust Company, N.A.	5.571.831	-51.300	31-3-2024
0,27 %	China Asset Management Co., Ltd.	5.254.667	946.805	31-12-2023
0,20 %	HuaAn Fund Management Co., Ltd.	3.845.988	-352.900	31-12-2023
0,18 %	INVESCO Great Wall Fund Management Co. Ltd.	3.495.355	-11.000	31-12-2023
0,17 %	BlackRock Advisors (UK) Limited	3.350.579	116.000	31-3-2024
0,16 %	Wellington Management Company, LLP	3.134.300	252.100	29-2-2024
0,13 %	CIB Fund Management Co., Ltd.	2.568.900	-59.700	31-12-2023
0,12 %	Huashang Fund Management Co., Ltd.	2.258.756	2.258.756	31-12-2023
0,11 %	Franklin Templeton Sealand Fund Management Co., Ltd.	2.054.100	-20.800	31-12-2023
0,10 %	BlackRock Investment Management, LLC	2.024.760	178.600	31-12-2023
0,09 %	Tianhong Asset Management Co., Ltd.	1.739.387	-4.300	31-12-2023
0,09 %	Charles Schwab Investment Management, Inc.	1.693.400	1.421.900	31-3-2024
0,08 %	Purekind Fund Management Co., Ltd.	1.500.010	870.010	30-6-2023
0,07 %	HSBC JinTrust Fund Management Co., Ltd.	1.392.100	-1.060.759	31-12-2023
0,07 %	Harvest Fund Management Co., Ltd.	1.373.328	0	29-2-2024
0,06 %	Geode Capital Management, L.L.C.	1.249.500	3.200	29-2-2024
0,06 %	Penghua Fund Management Co., Ltd.	1.227.500	972.700	30-6-2023
0,05 %	Guotai Junan Securities Assets Management Co., Ltd.	1.003.200	-66.200	30-6-2023
0,05 %	China Merchants Fund Management Co. Ltd.	974.217	36.800	31-12-2023
0,05 %	Bosera Asset Management Co., Ltd.	872.100	816.700	31-12-2023
0,04 %	Harvest Global Investments Limited	867.550	0	31-3-2024
0,04 %	BOC International (China) Ltd.	750.000	-50.000	31-12-2023
0,04 %	China Asset Management (Hong Kong) Limited	739.600	49.200	31-3-2024
0,04 %	Caitong Securities Asset Management Co., Ltd.	706.400	706.400	30-6-2023
0,04 %	DWS Investments UK Limited	693.169	-3.145	31-3-2024
0,04 %	Guotai Asset Management Co., Ltd.	686.108	25.500	31-12-2023
0,04 %	Hwabao WP Fund Management Co., Ltd.	679.800	-7.400	31-12-2023
0,03 %	BlackRock Financial Management, Inc.	671.700	589.400	31-10-2023
0,03 %	Rongtong Fund Management Co., Ltd.	646.000	646.000	30-6-2023
0,03 %	Everbright PGIM Fund Management Co., Ltd.	596.000	596.000	30-6-2023
0,03 %	Zheshang Fund Management Co., Ltd.	591.600	-552.438	31-12-2023
0,03 %	State Street Global Advisors (US)	567.479	326	29-2-2024
0,03 %	Changsheng Fund Management Co., Ltd.	539.337	0	31-12-2023
0,02 %	Focusbridge Investments Limited	475.000	475.000	30-6-2023
0,02 %	SWS MU Fund Management Co., Ltd.	467.524	290.000	31-12-2023
0,02 %	Swedbank Robur Fonder AB	467.300	0	29-2-2024
0,02 %	Aviva Investors Global Services Limited	422.396	164.266	29-2-2024
0,02 %	UBS Asset Management (UK) Ltd.	415.705	1.400	31-3-2024
0,02 %	Chang Xin Asset Management Co., Ltd.	399.700	57.100	31-12-2023
0,02 %	BlackRock (Singapore) Limited	390.914	92.900	31-3-2024
0,02 %	Amundi Asset Management, SAS	388.600	-88.600	31-3-2024
0,02 %	BlackRock Asset Management North Asia Limited	381.600	0	31-12-2023
0,02 %	Credit Suisse Funds AG	325.700	-6.600	31-3-2024
0,02 %	UBS Asset Management (Switzerland)	320.700	0	29-2-2024
0,02 %	Northern Trust Global Investments Limited	310.600	30.500	29-2-2024
0,02 %	California State Teachers Retirement System	304.100	103.400	30-6-2023
0,02 %	Taiping Fund Management Co., Ltd.	292.900	292.900	30-6-2023
0,01 %	State Street Global Advisors (UK) Ltd.	268.410	1	31-3-2024
0,01 %	CCB Principal Asset Management Co., Ltd.	250.654	-358.300	31-12-2023
0,01 %	JPMorgan Asset Management (China) Company Limited.	245.300	25.600	30-6-2023
0,01 %	First-Trust Fund Management Co., Ltd.	236.200	0	31-12-2023
0,01 %	Fuanda Fund Management Co., Ltd.	233.000	-47.500	31-12-2023
0,01 %	BlackRock Investment Management (UK) Ltd.	232.100	0	29-2-2024
0,01 %	Krane Funds Advisors, LLC	229.694	5.700	31-3-2024
0,01 %	Wilmington Trust Investment Management LLC	222.800	0	29-2-2024
0,01 %	Nuveen LLC	221.732	0	31-3-2024
0,01 %	Taikang Asset Management Co., Ltd.	212.300	200.100	30-6-2023
0,01 %	Tibet Eastmoney Fund Management Co., Ltd.	210.900	-22.700	31-12-2023
0,01 %	DWS Investment GmbH	202.802	-5.400	31-3-2024
0,01 %	CPIC Fund Management Co., Ltd.	196.746	-3.300	31-12-2023
0,01 %	HSBC Global Asset Management (UK) Limited	195.347	0	29-2-2024
0,01 %	Goldman Sachs Asset Management, L.P.	193.614	-5.802	31-3-2024
0,01 %	HFT Investment Management Co., Ltd.	164.200	-1.800	31-12-2023
0,01 %	Amundi Japan Ltd.	138.400	-5.400	31-3-2024
0,01 %	Mercer Global Investments Management Ltd	136.700	0	31-3-2024
0,01 %	Invesco Capital Management LLC	136.570	0	31-3-2024
0,01 %	Fubon Asset Management Company Ltd.	117.854	-10.600	29-2-2024
0,01 %	Zürcher Kantonalbank (Asset Management)	117.400	0	29-2-2024
0,01 %	Handelsbanken Kapitalförvaltning AB	112.500	0	31-3-2024
0,01 %	Pictet Asset Management Ltd.	112.300	-8.200	31-12-2023
0,01 %	Legal & General Investment Management Ltd.	111.130	0	29-2-2024
0,01 %	Truvalue Asset Management Co., Ltd.	106.900	106.900	30-6-2023
0,01 %	HSBC Global Asset Management (Hong Kong) Limited	102.745	-522.900	31-12-2023
0,01 %	BOCI-Prudential Asset Management Ltd.	100.915	800	29-2-2024
0,01 %	China Fund Management Co., Ltd.	100.000	-87.100	30-6-2023
0,01 %	Maxwealth Fund Management Co., Ltd.	98.800	91.600	30-6-2023
0,00 %	BMO Asset Management Inc.	86.236	0	31-3-2024
0,00 %	Wanjia Asset Management Co., Ltd.	85.981	-2.000	31-12-2023
0,00 %	China Life AMP Asset Management Co., Ltd	84.000	-2.000	31-12-2023
0,00 %	WCM Investment Management	83.700	-13.900	31-12-2023
0,00 %	JT Asset Management Co., Ltd.	82.500	78.300	30-6-2023
0,00 %	ABC-CA Fund Management Co., Ltd.	82.100	-110.300	31-12-2023
0,00 %	Cardano Asset Management NV	74.491	7	29-2-2024
0,00 %	Ping An Fund Management Company Limited	72.800	700	31-12-2023
0,00 %	Shen (Bo)	71.700	0	31-12-2023

Naam	Relatie	Tweewekencorrelatie	Eenmaandskorrelatie	Driemaands correlatie	Zesmaandscorrelatie	Eenjaarscorrelatie	Tweejaarscorrelatie
Shenzhen Chipscreen Biosciences A	LeverancierKlant	0,99	0,84	-0,03	-0,30	-	0,07
Shandong Wohua Pharm	LeverancierKlant	0,99	0,92	0,68	0,59	0,66	0,28
Gan & Lee Pharmaceuticals A	LeverancierKlant	0,97	0,92	0,09	-0,21	0,42	-
Shanghai Jiao Yun Gp A	LeverancierKlant	0,97	0,56	0,61	0,65	0,64	0,39
Super Telecom A	LeverancierKlant	0,97	0,93	0,80	0,18	0,27	-
Betta Pharmaceuticals A	LeverancierKlant	0,96	0,97	0,18	-0,25	0,21	0,15
Essence Info A	LeverancierKlant	0,95	0,93	-0,14	-0,14	0,12	-
Shanghai Haixin Group A	LeverancierKlant	0,94	0,76	0,33	-0,07	-0,07	0,08
Enzymatica	LeverancierKlant	0,93	0,76	0,53	-0,14	0,12	0,08
Greenland -A-	LeverancierKlant	0,90	0,89	0,41	0,52	0,68	-

What values and corporate philosophy does Shanghai Pharmaceuticals Holding Co represent?

Shanghai Pharmaceuticals Holding Co Ltd embodies a set of values and a corporate philosophy that underpin its operations. The company believes in delivering high-quality healthcare products and services to meet the evolving needs of its customers. Shanghai Pharmaceuticals focuses on fostering innovation, maintaining integrity, and ensuring sustainable development. By prioritizing the well-being of patients and healthcare professionals, the company strives to enhance public health and contribute to society. Shanghai Pharmaceuticals' commitment to improving medical access and advancing healthcare systems reflects its dedication to delivering value and making a positive impact in the pharmaceutical industry.

In which countries and regions is Shanghai Pharmaceuticals Holding Co primarily present?

Shanghai Pharmaceuticals Holding Co Ltd operates primarily in China. As a leading pharmaceutical company based in Shanghai, China, it has established a strong presence in its home country. With an extensive network and many subsidiaries across China, Shanghai Pharmaceuticals Holding Co Ltd serves a vast market within the country. Its presence and influence in the Chinese pharmaceutical industry contribute to its position as a key player in the region.

What significant milestones has the company Shanghai Pharmaceuticals Holding Co achieved?

Shanghai Pharmaceuticals Holding Co Ltd has achieved several significant milestones in its corporate history. The company has successfully established itself as a leading player in the pharmaceutical sector in China. Shanghai Pharmaceuticals Holding Co Ltd has expanded its business operations both domestically and internationally, through strategic acquisitions and partnerships. The company has demonstrated continued growth and stability, with a diversified product portfolio and a strong presence in key therapeutic areas. Shanghai Pharmaceuticals Holding Co Ltd has consistently focused on innovation, research and development, and delivering high-quality healthcare products and services. Through its continuous efforts, the company has garnered recognition and trust from both investors and consumers alike.

What is the history and background of the company Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co Ltd, established in 1994, is a renowned Chinese pharmaceutical company. With its headquarters in Shanghai, the company has a rich history and exceptional background in the healthcare industry. Shanghai Pharmaceuticals operates across various segments, including the production, distribution, and retail of pharmaceutical and healthcare products. Over the years, it has expanded its business both domestically and internationally, becoming a leading player in China's pharmaceutical market. With a strong focus on research and development, Shanghai Pharmaceuticals has established strategic partnerships and collaborations with global pharmaceutical giants, further enhancing its position in the industry. This company's commitment to innovation, quality, and customer satisfaction has contributed to its success and widespread recognition.

Who are the main competitors of Shanghai Pharmaceuticals Holding Co in the market?

Some of the main competitors of Shanghai Pharmaceuticals Holding Co Ltd in the market include China Resources Pharmaceutical Group Limited, Jiangsu Hengrui Medicine Co Ltd, and Sinopharm Group Co Ltd.

In which industries is Shanghai Pharmaceuticals Holding Co primarily active?

Shanghai Pharmaceuticals Holding Co Ltd is primarily active in the pharmaceutical industry. As one of the leading pharmaceutical companies in China, it operates in various sectors including research and development, manufacturing, distribution, and retail. With a diversified product portfolio, Shanghai Pharmaceuticals caters to a wide range of healthcare needs, including prescription drugs, over-the-counter medications, traditional Chinese medicine, medical devices, and healthcare services. The company's strong presence and expertise in the pharmaceutical industry enable it to contribute significantly to the advancement of healthcare and improve the quality of life for individuals across China and beyond.

What is the business model of Shanghai Pharmaceuticals Holding Co?

The business model of Shanghai Pharmaceuticals Holding Co Ltd is focused on pharmaceutical production, distribution, and retail sales. As one of China's leading integrated pharmaceutical companies, Shanghai Pharmaceuticals engages in research and development, manufacturing, marketing, and sales of both innovative and generic drugs. The company operates a comprehensive supply chain, including procurement, distribution, and retailing services. By combining its strong domestic presence with international expansion, Shanghai Pharmaceuticals aims to deliver high quality and affordable healthcare products to improve public health in China and beyond.

Welke K/W-verhouding heeft Shanghai Pharmaceuticals Holding Co 2024?

De Shanghai Pharmaceuticals Holding Co K/W is 26,41.

Welke K/W heeft Shanghai Pharmaceuticals Holding Co 2024?

De Shanghai Pharmaceuticals Holding Co KUV is 0,24.

Welke AlleAktien Kwaliteitsscore heeft Shanghai Pharmaceuticals Holding Co?

De AlleAktien Kwaliteitsscore voor Shanghai Pharmaceuticals Holding Co is 7/10.

Hoe hoog is de omzet van Shanghai Pharmaceuticals Holding Co 2024?

De verwachte Shanghai Pharmaceuticals Holding Co omzet is 291,16 mld. CNY.

Hoe hoog is de winst van Shanghai Pharmaceuticals Holding Co 2024?

De verwachte Shanghai Pharmaceuticals Holding Co winst is 2,70 mld. CNY.

Wat doet Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co Ltd is a leading Chinese pharmaceutical conglomerate that was founded in 1994. The company is headquartered in Shanghai and consists of various divisions, including pharmaceutical manufacturing, medication distribution, research and development, and chemical production. The company offers a wide range of products that are used in various fields of medicine. This includes antidepressants, analgesics, antipyretics, cardiology, and oncology. Additionally, the company also provides traditional Chinese medicine products and medical accessories. The pharmaceutical production division is one of the most important for the company. Here, Shanghai Pharmaceuticals produces a wide range of pharmaceuticals, including generics and patented products. The company has a strong research and development department specialized in producing highly effective drugs for various medical conditions. Another important area for the company is medication distribution. The company has a network of distribution partners that help distribute the products to different countries and regions. Shanghai Pharmaceuticals has branches in many countries and regions, including Thailand, Australia, and the USA. The company also has a strong presence in traditional Chinese medicine and offers a variety of products, including herbal blends and herbal capsules. These products have been used in Chinese culture for thousands of years and are popular among people worldwide. Shanghai Pharmaceuticals also has its own research and development department that is involved in the development of some very important drugs. The company specializes in developing drugs for chronic diseases such as diabetes, cancer, and cardiovascular diseases. In addition to pharmaceutical production, the company also offers some chemical products. Shanghai Pharmaceuticals manufactures various chemicals such as intermediates used in the pharmaceutical industry. These products are often used as raw materials for drug manufacturing. Overall, Shanghai Pharmaceuticals' business model is very successful, and the company is one of the leading Chinese companies in the pharmaceutical industry. The company has established itself as a reliable partner for various medical products and services, and is expected to continue growing in the future.

Hoe hoog is het Shanghai Pharmaceuticals Holding Co dividend?

Shanghai Pharmaceuticals Holding Co keert een dividend van 0,42 CNY uit, verdeeld over betalingen per jaar.

Hoe vaak keert Shanghai Pharmaceuticals Holding Co dividend uit?

De dividend kan momenteel niet worden berekend voor Shanghai Pharmaceuticals Holding Co of het bedrijf keert geen dividend uit.

Wat is de Shanghai Pharmaceuticals Holding Co ISIN?

De ISIN van Shanghai Pharmaceuticals Holding Co is CNE000000C82.

Wat is de Shanghai Pharmaceuticals Holding Co ticker?

De ticker van Shanghai Pharmaceuticals Holding Co is 601607.SS.

Hoeveel dividend betaalt Shanghai Pharmaceuticals Holding Co?

Binnen de laatste 12 maanden betaalde Shanghai Pharmaceuticals Holding Co een dividend van 0,61 CNY . Dit komt overeen met een dividendrendement van ongeveer 3,17 %. Voor de komende 12 maanden zal Shanghai Pharmaceuticals Holding Co naar verwachting een dividend van 0,65 CNY betalen.

Wat is het dividendrendement van Shanghai Pharmaceuticals Holding Co?

De dividendrendement van Shanghai Pharmaceuticals Holding Co is momenteel 3,17 %.

Wanneer betaalt Shanghai Pharmaceuticals Holding Co dividend?

Shanghai Pharmaceuticals Holding Co betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden augustus, augustus, augustus, augustus.

Hoe veilig is het dividend van Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co betaalde de afgelopen 19 jaar elk jaar dividend.

Hoe hoog is het dividend van Shanghai Pharmaceuticals Holding Co?

Voor de komende 12 maanden wordt een dividend van 0,65 CNY verwacht. Dit komt overeen met een dividendrendement van 3,36 %.

In welke sector bevindt zich Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co wordt toegewezen aan de sector 'Gezondheid'.

Wann musste ich die Aktien von Shanghai Pharmaceuticals Holding Co kaufen, um die vorherige Dividende zu erhalten?

Om het laatste dividend van Shanghai Pharmaceuticals Holding Co van 20-7-2023 ter hoogte van 0,61 CNY te ontvangen, moest je het aandeel voor de ex-datum op 20-7-2023 in je portefeuille hebben.

Wanneer heeft Shanghai Pharmaceuticals Holding Co het laatste dividend uitbetaald?

De laatste dividenduitkering vond plaats op 20-7-2023.

Hoe hoog was het dividend van Shanghai Pharmaceuticals Holding Co in het jaar 2023?

In het jaar 2023 heeft Shanghai Pharmaceuticals Holding Co 0,42 CNY aan dividenden uitgekeerd.

In welke valuta keert Shanghai Pharmaceuticals Holding Co het dividend uit?

De dividenden van Shanghai Pharmaceuticals Holding Co worden in CNY uitgekeerd.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5,62
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,71	2,28
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	164,00	-131,00
-73,00	-119,00	-213,00	-312,00	-106,00	-373,00	-179,00	-445,00	-453,00	-373,00	-1.869,00	-1.981,00	-2.500,00	-6.182,00	-6.961,00	-7.413,00	-8.736,00	-9.641,00	-10.469,00	-15.349,00	-16.387,00	-17.141,00	-18.394,00	-17.530,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-31,00	-31,00	-108,00	-261,00	-238,00	-95,00	-90,00	-124,00	-240,00	-268,00	-1.304,00	-1.629,00	-2.090,00	-2.457,00	-2.551,00	-2.802,00	-3.150,00	-3.576,00	-3.686,00	-5.638,00	-5.621,00	-5.849,00	-6.239,00	-8.853,00
0,16	0,15	0,07	0,10	0	0,06	0,07	0,63	0,49	0,29	1,91	2,21	1,77	1,15	0,97	1,34	1,35	1,95	2,65	3,14	6,02	6,84	5,06	4,74
-52,00	-141,00	-144,00	-279,00	-169,00	-254,00	-198,00	-180,00	-192,00	-90,00	-765,00	-573,00	-413,00	-708,00	-905,00	-1.291,00	-1.720,00	-2.119,00	-2.007,00	-1.943,00	-2.753,00	-3.010,00	-4.118,00	-2.684,00
-225,00	-120,00	-202,00	-99,00	-404,00	-234,00	-275,00	-13,00	-173,00	349,00	287,00	-2.988,00	-3.790,00	-174,00	-892,00	-1.844,00	-1.908,00	-2.889,00	-2.355,00	-7.692,00	-4.584,00	-1.705,00	-6.015,00	-12.473,00
-0,17	0,02	-0,06	0,18	-0,24	0,02	-0,08	0,17	0,02	0,44	1,05	-2,42	-3,38	0,53	0,01	-0,55	-0,19	-0,77	-0,35	-5,75	-1,83	1,30	-1,90	-9,79
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,31	0,27	-0,50	0,25	0,41	0,21	0,30	-0,25	-0,16	-0,04	-0,46	0,84	-1,40	-0,81	1,09	1,26	2,16	1,69	3,87	10,40	1,71	1,69	4,33	3,84
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,24	0,14	0,07	0,13	0,24	0,09	0,09	-0,40	-0,34	-0,27	-0,61	2,09	10,64	-2,25	-0,72	-0,95	0,64	0,65	2,31	7,53	-2,33	-1,26	1,57	12,14
-0,07	-0,06	0,63	0,00	0	0,01	0	-0,01	-0,02	-0,03	0,39	2,00	13,01	-0,28	-0,53	-0,63	0,10	0,67	0,47	-0,19	-1,45	-0,53	-0,09	11,40
0	-72,00	-49,00	-122,00	-166,00	-128,00	-210,00	-147,00	-154,00	-211,00	-537,00	-749,00	-969,00	-1.157,00	-1.284,00	-1.576,00	-1.628,00	-1.712,00	-2.032,00	-2.677,00	-2.584,00	-2.418,00	-2.675,00	-3.093,00
0,44	0,46	0,33	0,81	0,19	0,45	0,23	1,42	1,16	1,29	6,68	7,13	14,71	8,54	9,83	10,10	13,32	14,87	19,39	27,16	27,14	33,70	30,26	35,52
112,20	5,10	-79,00	-178,60	-169,10	-192,70	-125,10	452,50	294,10	195,20	1.145,80	1.637,60	1.358,90	441,90	68,30	44,20	-371,30	-172,60	641,50	1.192,10	3.269,30	3.834,70	942,55	2.058,50
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Directe emissies	117.174,96
Indirecte emissies van ingekochte energie	333.124,49
Indirecte emissies binnen de waardeketen	—
CO₂-uitstoot	450.299,45
CO₂-reductiestrategie	✅
Steenkoolenergie	❌
Kernenergie	❌
Dierproeven	✅
Pelz & Leder	—
Bestrijdingsmiddelen	—
Palmolie	—
Tabak	❌
Genetische technologie	❌
Klimaatconcept	—
Duurzame bosbouw	—
Recyclingvoorschriften	✅
Milieuvriendelijke verpakking	✅
Gevaarlijke stoffen	✅
Brandstofverbruik en -efficiëntie	❌
Waterverbruik en -efficiëntie	✅

Aandeel vrouwelijke werknemers	50,3
Aandeel vrouwen in het management	—
Aandeel Aziatische werknemers	—
Aandeel Aziatisch management	—
Aandeel Spaans/Latijns-Amerikaanse werknemers	—
Aandeel Hispano/Latino management	—
Aandeel zwarte werknemers	—
Aandeel zwart management	—
Aandeel blanke werknemers	—
Aandeel wit management	—
Volwasseneninhoud	❌
Alcohol	❌
Defensie	—
Vuurwapens	❌
kansspel	❌
Militaire contracten	❌
Mensenrechtenconcept	✅
Privacybeleid	—
Arbeids- en gezondheidsbescherming	✅
Katholiek	✅

Duurzaamheidsverslag	✅
Stakeholder-Engagement	✅
Terugbelbeleid	❌
Mededingingsrecht	❌

Shanghai Pharmaceuticals Holding Co Ticker	Shanghai Pharmaceuticals Holding Co FIGI
601607:CH	BBG000BKDQ46
601607:CG	BBG000BKDQG3
601607:C1	BBG00709JCF1

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
4,41	4,53	4,60	5,20	7,24	9,79	10,82	10,70	12,64	13,92	16,55	31,26	38,53	54,90	68,08	78,22	92,40	105,52	120,77	130,85	159,08	186,57	191,91	215,82	231,98	260,30	291,16	322,76	357,23
-	2,65	1,43	13,21	39,10	35,24	10,52	-1,07	18,13	10,14	18,88	88,91	23,26	42,48	24,00	14,90	18,12	14,20	14,45	8,35	21,58	17,28	2,86	12,46	7,49	12,21	11,86	10,86	10,68
11,67	12,05	12,67	13,40	13,93	10,16	9,24	6,41	8,26	8,63	8,60	18,71	17,71	14,31	13,56	12,98	12,24	11,92	11,73	12,73	13,96	14,22	14,09	13,20	13,14	11,92	-	-	-
0,52	0,55	0,58	0,70	1,01	0,99	1,00	0,69	1,04	1,20	1,42	5,85	6,83	7,86	9,23	10,15	11,31	12,57	14,16	16,66	22,21	26,52	27,04	28,49	30,48	31,02	0	0	0
0,13	0,18	0,18	0,17	0,19	0,16	0,12	0,09	0,12	0,22	0,21	1,28	1,76	2,34	2,55	2,79	3,21	3,62	3,74	5,06	5,71	7,37	7,74	7,80	8,32	8,86	9,86	11,21	12,63
2,95	4,00	3,83	3,33	2,64	1,61	1,12	0,84	0,95	1,58	1,26	4,08	4,57	4,25	3,75	3,56	3,48	3,43	3,10	3,87	3,59	3,95	4,03	3,61	3,58	3,40	3,39	3,47	3,54
0,06	0,09	0,16	0,14	0,13	0,14	0,09	0,05	-0,04	0,07	0,08	1,30	1,27	2,04	2,05	2,24	2,59	2,88	3,20	3,52	3,88	4,08	4,50	5,09	5,62	3,77	2,70	3,04	3,50
-	56,67	72,34	-11,73	-11,89	8,73	-34,31	-43,33	-176,47	-269,23	24,24	1.481,71	-2,39	61,30	0,54	9,25	15,51	11,04	11,09	10,17	10,22	5,15	10,17	13,28	10,29	-32,92	-28,42	12,61	15,38
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,51	0,53	0,53	0,57	0,57	0,57	0,57	0,57	0,57	0,57	0,57	1,99	1,99	2,42	2,69	2,69	2,69	2,69	2,69	2,69	2,83	2,83	2,85	2,85	3,48	3,70	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Doe de beste investeringen van je leven

Beurskoers

koers

Ticker601607.SS

ISINCNE000000C82

Shanghai Pharmaceuticals Holding Co Aandeel Omzet, EBIT, Winst CNE000000C82 ·

Omzet, Winst & EBIT

Begrip van omzet, EBIT en inkomen

Jaarlijkse analyse en vergelijkingen

Verwachtingen voor de investering benutten

Investeringinzichten

Shanghai Pharmaceuticals Holding Co Omzet, Winst en EBIT Geschiedenis

Shanghai Pharmaceuticals Holding Co Aandelen Kengetallen

GuV

Omzet en groei

Brutomarge

EBIT en EBIT-marge

Inkomen en groei

Uitstaande aandelen

Interpretatie van de jaarlijkse vergelijking

Verwachtingen en voorspellingen

Balans

Begrip van de balans

Activa

Passiva

Eigen Vermogen

Jaar-op-jaar analyse

Interpretatie van de gegevens

Shanghai Pharmaceuticals Holding Co Aandeel Marges CNE000000C82 ·

Margen

Begrip van de brutomarge

Analyse van de EBIT-marge

Inzichten in de omzetmarge

Verwachtingen interpreteren

Vergelijkende analyse

Shanghai Pharmaceuticals Holding Co Margesgeschiedenis

Shanghai Pharmaceuticals Holding Co Aandeel Omzet, EBIT, Winst per aandeel CNE000000C82 ·

Omzet, EBIT en Winst per Aandeel

Omzet per Aandeel

EBIT per Aandeel

Inkomen per Aandeel

Verwachte Waarden

Shanghai Pharmaceuticals Holding Co Omzet, winst en EBIT per aandeel historie

Shanghai Pharmaceuticals Holding Co Aandeel en aandelenanalyse

Shanghai Pharmaceuticals Holding Co Beoordeling op basis van historische K/W, EBIT en K/W-verhouding

Shanghai Pharmaceuticals Holding Co Aantal aandelen CNE000000C82 ·

Omzet, EBIT en Winst per Aandeel

Omzet per Aandeel

EBIT per Aandeel

Inkomen per Aandeel

Verwachte Waarden

Shanghai Pharmaceuticals Holding Co Aandelensplitsingen

Shanghai Pharmaceuticals Holding Co Aandeel Dividend CNE000000C82 ·

Dividende

Overzicht van dividenden

Interpretatie en gebruik

Investeringstrategie

Shanghai Pharmaceuticals Holding Co Dividendengeschiedenis

Shanghai Pharmaceuticals Holding Co Aandeel Uitkeringsratio CNE000000C82 ·

Uitkeringsratio

Wat is de jaarlijkse uitkeringsratio?

Zo interpreteert u de gegevens

Gebruik van de gegevens voor investeringen

Shanghai Pharmaceuticals Holding Co Dividenduitkeringsratio historie

Shanghai Pharmaceuticals Holding Co Winstschattingen

Shanghai Pharmaceuticals Holding Co Winstverrassingen

Eulerpool ESG Rating voor het aandeel Shanghai Pharmaceuticals Holding Co

Eulerpool World ESG Rating (EESG©)

84/ 100

🌱 Environment

👫 Social

🏛️ Governance

Milieu (Environment)

Sociaal (Social)

Bedrijfsvoering (Governance)

Shanghai Pharmaceuticals Holding Co Aandeel Aandeelhoudersstructuur

Shanghai Pharmaceuticals Holding Co toeleveringsketen

Veelgestelde vragen over het Shanghai Pharmaceuticals Holding Co aandeel

What values and corporate philosophy does Shanghai Pharmaceuticals Holding Co represent?

In which countries and regions is Shanghai Pharmaceuticals Holding Co primarily present?

Ticker
601607.SS

ISIN
CNE000000C82